LI, GANG,WEI, GE,HORNBY, ZACHARY D.,LIM, JONATHAN EE-REN
申请号：
CA3008663
公开号：
CA3008663A1
申请日:
2016.12.15
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
Described herein are combinations comprising a therapeutically effective amount of a first agent and a therapeutically effective amount of a second agent, wherein the first agent is an inhibitor of ALK, ROSl, TrkA, TrkB, or TrkC activity, or a combination thereof, and methods of using such combinations in the treatment of patients having cancer.
